ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ISCO

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
04/10/2018	8:45AM	InvestorsHub NewsWire	International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results	USOTC:ISCO	International Stem Cell Corporation (QB)
04/09/2018	6:08AM	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
04/04/2018	1:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
04/03/2018	6:38PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
04/03/2018	6:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
04/02/2018	4:02PM	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
03/27/2018	8:45AM	InvestorsHub NewsWire	International Stem Cell Corporation Executive Receives Bioscience Chief Scientific Officer of the Year Award	USOTC:ISCO	International Stem Cell Corporation (QB)
03/14/2018	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
03/14/2018	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
03/08/2018	5:21PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
03/08/2018	10:13AM	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ISCO	International Stem Cell Corporation (QB)
03/05/2018	8:30AM	InvestorsHub NewsWire	International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)
02/22/2018	3:36PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
02/22/2018	3:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
02/21/2018	3:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
02/01/2018	3:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
01/31/2018	5:28PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:ISCO	International Stem Cell Corporation (QB)
01/22/2018	8:45AM	InvestorsHub NewsWire	International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research	USOTC:ISCO	International Stem Cell Corporation (QB)
01/11/2018	8:45AM	InvestorsHub NewsWire	International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks	USOTC:ISCO	International Stem Cell Corporation (QB)
01/02/2018	5:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
01/02/2018	5:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
01/02/2018	5:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
12/13/2017	3:08PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
12/12/2017	3:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
12/08/2017	2:36PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
12/08/2017	1:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
11/29/2017	8:30AM	InvestorsHub NewsWire	International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease	USOTC:ISCO	International Stem Cell Corporation (QB)
11/17/2017	8:30AM	InvestorsHub NewsWire	International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017	USOTC:ISCO	International Stem Cell Corporation (QB)
11/14/2017	6:11AM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
11/13/2017	8:30AM	InvestorsHub NewsWire	International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)